Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Consistent epidemiological evidence exists linking low vitamin D levels to increased risk and severity of respiratory tract infections.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Scoping review.

Scoping review

Maps the extent and characteristics of research on a topic.

Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Association Between Vitamin D and Novel SARS-CoV-2 Respiratory Dysfunction: A Scoping Review of Current Evidence and Its Implication for COVID-19 Pandemic

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Association Between Vitamin D and Novel SARS-CoV-2 Respiratory Dysfunction: A Scoping Review of Current Evidence and Its Implication for COVID-19 Pandemic

Scoping review · Frontiers in Physiology · 2020

Original publication title

Association Between Vitamin D and Novel SARS-CoV-2 Respiratory Dysfunction: A Scoping Review of Current Evidence and Its Implication for COVID-19 Pandemic

Aida Santaolalla; Kerri Beckmann; Joyce Kibaru; Debra Josephs; Mieke Van Hemelrijck; Sheeba Irshad

Copyright © 2020 Santaolalla, Beckmann, Kibaru, Josephs, Van Hemelrijck and Irshad.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Our rapid review of literature supports the need for observational studies with COVID-19 infected populations to measure and assess vitamin D levels in relation to risk/severity and outcomes; alongside RCTs designed to evaluate the efficacy of supplementation both in preventive and therapeutic contexts. The overlap in the vitamin D associated biological pathways with the dysregulation reported to drive COVID-19 outcomes warrants further investigation.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

To assess the association between vitamin D deficiency and increased morbidity/mortality with COVID-19 respiratory dysfunction.

Source: Objectives

Abstract: Design

Scoping review.

Source: Design

Abstract: Data Sources

Ovid MEDLINE (1946 to 24 of April 2020) and PubMed (2020 to 17 of September 2020).

Source: Data Sources

Abstract: Eligibility Criteria for Selecting Studies

A search using the search terms: [(cholecalciferol or ergocalciferol or vitamin D2 or vitamin D3 or vitamin D or 25OHD) and (SARS-CoV-2 or coronavirus or COVID or betacoronavirus or MERS-CoV or SARS-CoV or respiratory infection or acute respiratory distress syndrome or ARDS)]m.p. was conducted on the 24/04/2020 (Search A) and 17/09/2020 (Search B).

Source: Eligibility Criteria for Selecting Studies

Abstract: Results

91 studies were identified as being concerned with Acute Respiratory Infection (ARI)/Acute Respiratory Distress Syndrome (ARDS) and vitamin D, and 25 publications specifically explored the role of vitamin D deficiency in the development and progression of SARS-CoV-2/COVID-19 related ARDS. Search “A” identified three main themes of indirect evidence supporting such an association. Consistent epidemiological evidence exists linking low vitamin D levels to increased risk and severity of respiratory tract infections. We also report on plausible biological processes supporting such an association; and present weaker evidence supporting the benefit of vitamin D supplementation in reducing the risk and severity of ARIs.

Uncertainty remains about what constitutes an appropriate dosing regimen in relation to reducing risk/severity of ARI/ARDS. More recent evidence (Search B) provided new insights into some direct links between vitamin D and COVID-19; with a number of cohort and ecological studies supporting an association with PCR-positivity for SARS-CoV-2 and vitamin D deficiency. The exact efficacy of the vitamin D supplementation for prevention of, or as an adjunct treatment for COVID-19 remains to be determined; but a number of randomized control trials (RCTs) currently underway are actively investigating these potential benefits.

Source: Results

Abstract: Conclusion

Our rapid review of literature supports the need for observational studies with COVID-19 infected populations to measure and assess vitamin D levels in relation to risk/severity and outcomes; alongside RCTs designed to evaluate the efficacy of supplementation both in preventive and therapeutic contexts. The overlap in the vitamin D associated biological pathways with the dysregulation reported to drive COVID-19 outcomes warrants further investigation.

Source: Conclusion
Authors’ abstract

Objectives

To assess the association between vitamin D deficiency and increased morbidity/mortality with COVID-19 respiratory dysfunction.

Design

Scoping review.

Data Sources

Ovid MEDLINE (1946 to 24 of April 2020) and PubMed (2020 to 17 of September 2020).

Eligibility Criteria for Selecting Studies

A search using the search terms: [(cholecalciferol or ergocalciferol or vitamin D2 or vitamin D3 or vitamin D or 25OHD) and (SARS-CoV-2 or coronavirus or COVID or betacoronavirus or MERS-CoV or SARS-CoV or respiratory infection or acute respiratory distress syndrome or ARDS)]m.p. was conducted on the 24/04/2020 (Search A) and 17/09/2020 (Search B).

Results

91 studies were identified as being concerned with Acute Respiratory Infection (ARI)/Acute Respiratory Distress Syndrome (ARDS) and vitamin D, and 25 publications specifically explored the role of vitamin D deficiency in the development and progression of SARS-CoV-2/COVID-19 related ARDS. Search “A” identified three main themes of indirect evidence supporting such an association. Consistent epidemiological evidence exists linking low vitamin D levels to increased risk and severity of respiratory tract infections. We also report on plausible biological processes supporting such an association; and present weaker evidence supporting the benefit of vitamin D supplementation in reducing the risk and severity of ARIs.

Uncertainty remains about what constitutes an appropriate dosing regimen in relation to reducing risk/severity of ARI/ARDS. More recent evidence (Search B) provided new insights into some direct links between vitamin D and COVID-19; with a number of cohort and ecological studies supporting an association with PCR-positivity for SARS-CoV-2 and vitamin D deficiency. The exact efficacy of the vitamin D supplementation for prevention of, or as an adjunct treatment for COVID-19 remains to be determined; but a number of randomized control trials (RCTs) currently underway are actively investigating these potential benefits.

Conclusion

Our rapid review of literature supports the need for observational studies with COVID-19 infected populations to measure and assess vitamin D levels in relation to risk/severity and outcomes; alongside RCTs designed to evaluate the efficacy of supplementation both in preventive and therapeutic contexts. The overlap in the vitamin D associated biological pathways with the dysregulation reported to drive COVID-19 outcomes warrants further investigation.

Publication and source details

Original title: Association Between Vitamin D and Novel SARS-CoV-2 Respiratory Dysfunction: A Scoping Review of Current Evidence and Its Implication for COVID-19 Pandemic

Aida Santaolalla; Kerri Beckmann; Joyce Kibaru; Debra Josephs; Mieke Van Hemelrijck; Sheeba Irshad

Frontiers in Physiology · 2020

Edited by: Gaetano Santulli, Columbia University, United States

Reviewed by: William B. Grant, Sunlight, Nutrition, and Health Research Center, United States; Hari H. Subramanian, Boston Scientific, United States; Celestino Sardu, Second University of Naples, Italy

*Correspondence: Aida Santaolalla, aida.santaolalla@kcl.ac.uk; orcid.org/0000-0003-2748-3252

This article was submitted to Respiratory Physiology, a section of the journal Frontiers in Physiology

Copyright © 2020 Santaolalla, Beckmann, Kibaru, Josephs, Van Hemelrijck and Irshad.2020Santaolalla, Beckmann, Kibaru, Josephs, Van Hemelrijck and Irshadhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.Medical Research Council10.13039/501100000265

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T15:17:16.557161+00:00

DOI: 10.3389/fphys.2020.564387 · PMC7726316